PAYER POLICY CHANGES

J9225 Insurance Policy Changes

HCPCS J9225 is officially defined as "Histrelin implant (vantas), 50 mg." HCPCS J9225 is referenced in 2 tracked payer policy changes from Sentara Health Plans and Premera Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J9225 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch J9225

Get one email when a payer policy names J9225, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for J9225

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J9225 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.